A NAD+ nasal spray is NAD+, the coenzyme your cells use to turn food into energy, made up by a compounding pharmacy as a liquid you spray into your nose. Controlled human evidence for commercial sprays was not identified in our search.
It's a compounded prescription, sold mostly as a needle-free option
Providers sell nasal NAD+ as an alternative to shots. A clinician reviews an intake form, writes a prescription, and a pharmacy compounds the spray and ships it. Plans are usually sold as a monthly supply, though a few sell quarterly supplies or prepaid blocks of months.
There is no FDA-approved NAD+ nasal reference product. Strength, bottle size and inactive ingredients can differ between preparations. That's one reason this page doesn't compare products by strength: there's no reference product to compare them against.
Human clinical evidence remains limited
Our search of indexed literature did not identify a controlled human trial establishing the benefits of a commercial NAD+ nasal spray [7]. Animal experiments and uncontrolled clinical reports address particular conditions; they cannot establish routine energy or aging benefits.
- Rats, 2007: NAD+ given in the nose reduced brain damage after a stroke-like injury [8].
- Mice, 2009: nasal NAD+ increased brain NAD+ but did not reduce injury 24 hours after experimentally induced brain hemorrhage [1].
- Rats, 2012: the same approach reduced neuron death after traumatic brain injury [9].
- Mice and human cells, 2026: in mice with chemically induced loss of smell, NAD+ in the nose improved smell and repaired the lining that senses odors; it also helped human olfactory stem cells mature in a dish [10].
These are interesting results, but they are injury models in rodents. None measured energy, focus, sleep or aging, which is what sellers market the sprays for. None used a commercial nasal product, and none tells you what dose, if any, would do anything in a person.
| Route | Human studies | What they show |
|---|---|---|
| IV drip | A small saline-controlled pilot [11] | Plasma NAD+ did not rise during the first 2 hours of a 6-hour drip; the study did not establish wellness benefits |
| IV or intramuscular wellness use | No eligible wellness outcome trial in the cited review | The review searched only through October 2025; this is not proof that no newer or unpublished study exists |
| Nasal spray | Animal studies, uncontrolled cases and a provider customer survey | No identified controlled trial establishing current commercial-spray benefits |
NAD+ precursors taken by mouth (NMN, NR) are different compounds and are not counted here.
A conference case report presented in March 2022 describes one older woman with migraine who received intranasal NAD+ combined with lidocaine, followed by sublingual NAD+ [6]. She reported improvement, but there was no control group and multiple treatments were used. This catheter-administered combination is not a controlled trial of a commercial nasal spray. NAD Research funded the project, and the report acknowledges product suppliers. It cannot isolate an NAD+ effect or establish routine efficacy or safety.
A 2025 report followed three people with Parkinson's disease after six days of IV NAD+ and subsequent intranasal NAD+ mixed with lidocaine [2]. It used clinic questionnaires and had no control group. The symptom-improvement form did not offer a zero-improvement response. Prior IV treatment, lidocaine and other activities prevent attributing changes to nasal NAD+ alone; these findings do not establish commercial-spray benefits for healthy users.
AgelessRx also reports a commercial customer survey: 131 prescription-approved nasal-spray customers supplied self-reported check-in responses between April 2022 and October 2025, and the page says 89% reported benefits by the second check-in. This is a provider-reported survey, with no control group or blinded outcome assessment described on the page. Selection, expectations and other care could affect responses; the percentage is not a proven chance of benefit for a new buyer. [3]
Why IV and pill data don't carry over to sprays
It's tempting to borrow results from other forms of NAD+. They don't transfer well. In a 2019 pilot, plasma NAD+ did not rise during the first two hours of an IV infusion [11]. A nasal preparation uses a different route and formulation. The cited IV experiment cannot determine its absorption or clinical effects.
Oral products are a separate story again. Most pills sold for "NAD support" contain precursors such as NMN or NR, which the body converts. A 2026 systematic review, covering studies through October 2025, found that oral NR and NMN raise NAD-related markers but have mixed or null effects on health outcomes, and it found no qualifying outcome trials of injected NAD+ for wellness [12]. How precursors compare to NAD+ itself is covered in NMN vs NAD+.
The brain claim deserves its own caution. Some sellers suggest a nasal spray reaches the brain directly. In rats, NAD+ in the nose affected brain injury [8]. The cited evidence does not establish human brain delivery from a commercial spray.
Its status: Category 1 is conditional, not approval
FDA's 503A list, updated May 14, 2026, places "Nicotinamide Adenine Dinucleotide (NAD)" in Category 1, under evaluation [13]. The entry names the substance, not a route. A Category 1 listing does not approve a nasal product or waive the other conditions of the interim policy and section 503A.
The interim policy describes conditions under which FDA does not intend to act while evaluating nominated substances [14]. It isn't an approval, and no NAD+ nasal spray is FDA-approved. Compounded products aren't checked by FDA for safety or quality before sale.
Which kind of pharmacy makes your spray matters too. A 503B outsourcing facility must follow FDA's manufacturing-practice rules and is inspected on a risk-based schedule; a preparation meeting all section 503A conditions is exempt from federal CGMP requirements, while other federal and state obligations still apply [15].
Nasal spray or injection: what's actually different
Neither route has strong evidence, so neither can be called better for results. The differences are about what has been measured and what has gone wrong.
| Nasal spray | Injection | |
|---|---|---|
| Human evidence | No identified controlled commercial-spray trial | Small IV studies; those results do not establish effects of home injections |
| FDA status | No approved nasal product; conditional interim policy | No approved NAD+ injection; product and facility rules still apply |
| Documented quality problems | No nasal record in the cited query | 14 injectable product recall records [16] |
| Needles | No | Yes |
| Who decides if it suits you | Your prescriber | Your prescriber |
The recall record is the clearest difference. The queried FDA enforcement dataset contains 14 injectable-product recall records, with no nasal-spray record identified in those results [16]. Product records can refer to related recalls; they are not 14 independent incidents or a measure of patient harm. An absence from these search results does not establish spray safety. Injection risks are covered in are NAD+ injections safe, and whether injections help at all in do NAD+ injections work.
Convenience claims, such as easier use or faster absorption, come from sellers. The cited reports do not establish the absorption or human brain delivery of current commercial sprays.
Prices for NAD+ nasal spray
The offers below use different billing periods. Thirteen four-week periods equal 52 weeks; a calendar year is slightly longer. Actual payment counts depend on your start date and renewal schedule. Confirm the total, refill interval and cancellation terms before ordering.
| Provider | Monthly comparison |
|---|---|
| AgelessRx | $125/moMonthly subscription; $140 one-time offer also displayed [3] |
| HealthRX | $134/moOne-month subscription; lower per-month figures are listed for 3-, 6- or 12-month plans. Confirm the full amount due now [4] |
| Luvo Health | $216.18/mo$199 every four weeks after the introductory offer; monthly comparison figure shown [5] |
Offer pages checked October 22, 2026. Monthly price excludes introductory discounts. A monthly comparison figure does not change the actual four-week payment schedule.
Budget for the renewal amount rather than Luvo’s introductory discount. Where a longer plan offers a lower monthly figure, confirm the full amount due now and what happens if you stop early. Each provider's cancellation terms are in its check, using the method on how we check.
There is no reliable side-effect frequency for commercial sprays
Small uncontrolled case reports cannot establish a safety profile or side-effect frequency for commercial sprays. If you use one and notice nose irritation, headaches or anything else new, tell your prescriber. Ask the pharmacy what else is in the spray, since inactive ingredients differ between products.
What to ask before you order
- Which pharmacy compounds the spray, and is it a 503A pharmacy or a 503B outsourcing facility?
- What is the beyond-use date, and does the bottle need refrigeration?
- Is the price shown a first-month offer or the standing price?
- Can I cancel between refills, and how much notice is needed?
Clinic drips, a different product again, are covered in NAD+ IV therapy.